Clinical Trial Update: CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CD5024 1% ivermectin cream to metronidazole 0.75% cream in papulopustular rosacea; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Drugs mentioned

• CD5024 1% Ivermectin Cream (ivermectin)
• Metronidazole 0.75% Cream (metronidazole)

Snippet

Sponsor: Galderma R&D | Conditions: Papulopustular Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2015-10-28